News
The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era
Over the past few decades, the concept of self-care has evolved dramatically. Gone are the days when occasional spa days or simple checklists of personal hygiene were...
Press Releases
Infudopa SubC Parkinsons Therapy: Neuraxpharm-Dizlin Deal
Neuraxpharm Group (“Neuraxpharm”), a leading European specialty pharmaceutical company dedicated to central nervous system (CNS) disorders, and Dizlin Pharmaceuticals AB (“Dizlin”), a Swedish R&D company focused on...
News
Piramal Pharma Expands Lexington Sterile Injectables Plant
Piramal Pharma has started work on the expansion of its Lexington, Kentucky factory. Piramal Pharma held a groundbreaking ceremony at the plant on June 25, 2025, to...
Clinical Trials
Big Data Integration Transforming Clinical Trials
In the years that have gone by, the big data integration within clinical trials has gone on to emerge as a very transformative force within the healthcare industry,...
Articles
Pharmacovigilance Systems Gaining Higher Ground with AI
In a world that is marked by fast technological advancements, pharmacovigilance, which happens to be an essential element of drug safety, has gone on to start embracing...
Clinical Trials
Clinical Trial Supplies Market Worth $8.18 Billion by 2030
The market for clinical trial supplies is about to change a lot because there is a growing need for new ways to help people with their health...
Drug Research
China Unveils Innovative Drugs Policy to Boost Development
The National Health Commission and China's National Healthcare Security Administration (NHSA) together unveiled a comprehensive new policy on June 30 called "Several Measures to Support the High-Quality...
Press Releases
HALEON APPOINTS CARL HANEY AS CHIEF R&D OFFICER
Haleon today announces the appointment of Carl Haney as Chief Research & Development Officer. Carl will join Haleon on 1 August 2025.
This appointment follows Franck Riot deciding...
Drug Research
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
London, 28 June 2025 – In its ongoing mission to help meet America’s growing need for high-quality US-made medicines, Hikma Pharmaceuticals USA today announces it will invest...
BioPharma
AI in Genomics Market – Setting Pace for Vast Genomic Data
There is no shred of doubt that artificial intelligence in genomics is indeed reshaping the healthcare spectrum, offering unmatched opportunities to decode the intricacies of the human...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Media Packs
Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!
– Access the Media Pack Now
– Book a Conference Call
– Leave Message for Us to Get Back